血小板と動脈と静脈の冠動脈バイパス血管との異なる相互作用
Z H Yang1, P Stulz, L von Segesser
1Department of Research, University Hospital, Basel, Switzerland.
Lancet (London, England)
|April 20, 1991
まとめ
血小板は,内部乳腺動脈とサフェノス静脈と異なる相互作用をする. 血小板は酸化窒素によって動脈のリラックスを引き起こしますが,血栓素A2とセロトニンによって媒介される静脈の収縮を引き起こします.
科学分野:
- 心血管生物学 心血管生物学
- 血管生理学 血管生理学
- 血小板薬理学 血小板薬理学とは
背景:
- 血管壁と血小板の相互作用は,心臓血管の健康と疾患において極めて重要です.
- 異なる血管床におけるこれらの相互作用を理解することは,移植機能と治療戦略を最適化するための鍵です.
研究 の 目的:
- 人間の内部乳腺動脈 (IMA) とサフェノス静脈 (SV) のセグメントに対する血小板の集積の差異的な効果を調査する.
- 内皮,酸化窒素,血栓素A2,およびセロトニンの役割を含む,根本的なメカニズムを解明する.
主な方法:
- 孤立したヒトのIMAとSVのリングで,イソメトリックテンション測定.
- 内皮を化学的に除去し,特定の経路 (ADPase,酸化窒素合成酵素,血栓素およびセロトニン受容体) を薬理学的に遮断する.
- 様々な血小板濃度に対する濃度-反応曲線を分析した.
主要な成果:
- 血小板の集積は,ノラドレナリンで収縮したIMAで,酸化窒素の放出によって媒介された,内皮に依存したリラックスを引き起こした.
- 対照的に,血小板の集積は,ノラドレナリンで収縮したSVのさらなる収縮を引き起こし,酸化窒素とは無関係であった.
- 静止血管の血小板誘発収縮は,内皮を持つIMAでは存在しないが,SVでは存在し,強化された.
- アスピリンは収縮を減少させましたが,完全に廃止するには,静脈内のトロンボキサンA2とセロトニン受容体の遮断が必要でした.
結論:
- 血小板に由来するADPは,IMA内皮から酸化窒素の放出を誘発し,リラックスを促進します.
- トロンボキサンA2とセロトニンは,SVにおける血小板誘発収縮を媒介し,IMAとSVの間の差異的なメカニズムを強調しています.
- これらの血管特異的な血小板反応は,移植の通透性と抗血小板薬の有効性の違いを説明する可能性があります.
関連する概念動画
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...